| Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM C Estcourt, A Yeung, R Nandwani, D Goldberg, B Cullen, N Steedman, ... Aids 35 (4), 665-673, 2021 | 48 | 2021 |
| Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe)–a natural experiment (protocol) M Hickman, JF Dillon, L Elliott, D De Angelis, P Vickerman, G Foster, ... BMJ Open 9 (9), e029538, 2019 | 44 | 2019 |
| Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs A Yeung, NE Palmateer, JF Dillon, SA McDonald, S Smith, S Barclay, ... Journal of hepatology 76 (3), 549-557, 2022 | 42 | 2022 |
| Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community … NE Palmateer, A McAuley, JF Dillon, S McDonald, A Yeung, S Smith, ... Addiction 116 (10), 2893-2907, 2021 | 35 | 2021 |
| Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs NE Palmateer, DJ Goldberg, A Munro, A Taylor, A Yeung, LA Wallace, ... Addiction 113 (1), 80-90, 2018 | 33 | 2018 |
| Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study SJ Hutchinson, H Valerio, SA McDonald, A Yeung, K Pollock, S Smith, ... Gut 69 (12), 2223-2231, 2020 | 27 | 2020 |
| Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study A McAuley, R Fraser, M Glancy, A Yeung, HE Jones, P Vickerman, ... The Lancet Public Health 8 (7), e484-e493, 2023 | 26 | 2023 |
| A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage G Burton, A McAuley, J Schofield, A Yeung, C Matheson, T Parkes International Journal of Drug Policy 96, 103298, 2021 | 25 | 2021 |
| Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an … KMA Trayner, A McAuley, NE Palmateer, A Yeung, DJ Goldberg, ... Drug and alcohol dependence 232, 109263, 2022 | 24 | 2022 |
| Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection H Innes, P Jepsen, S McDonald, J Dillon, V Hamill, A Yeung, J Benselin, ... JHEP Reports 3 (6), 100384, 2021 | 20 | 2021 |
| Emergence of Novel Psychoactive Substance injecting associated with rapid rise in the population prevalence of hepatitis C virus A McAuley, A Yeung, A Taylor, SJ Hutchinson, DJ Goldberg, A Munro International Journal of Drug Policy 66, 30-37, 2019 | 20 | 2019 |
| Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study V Hamill, S Wong, J Benselin, M Krajden, PC Hayes, D Mutimer, A Yu, ... BMJ 382, 2023 | 18 | 2023 |
| Assessing the impact of a temporary class drug order on ethylphenidate‐related infections among people who inject drugs in Lothian, Scotland: an interrupted time‐series analysis A Yeung, A Weir, H Austin, K Morrison, D Inverarity, J Sherval, ... Addiction, 2017 | 16 | 2017 |
| Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon‐free therapies: A population‐based cohort study H Innes, SA McDonald, V Hamill, A Yeung, JF Dillon, PC Hayes, A Went, ... Liver International 42 (3), 561-574, 2022 | 15 | 2022 |
| Implementation of a national HIV pre-exposure prophylaxis service is associated with changes in characteristics of people with newly diagnosed HIV: a retrospective cohort study C Grimshaw, CS Estcourt, R Nandwani, A Yeung, D Henderson, ... Sexually Transmitted Infections 98 (1), 53-57, 2022 | 11 | 2022 |
| Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication? H Innes, V Hamill, SA McDonald, PC Hayes, P Johnson, JF Dillon, ... The American Journal of Gastroenterology 117 (9), 1454-1461, 2022 | 5 | 2022 |
| National increase in the community supply of take‐home naloxone associated with a mass media campaign in Scotland: a segmented time series analysis KMA Trayner, A Yeung, HR Sumnall, M Anderson, ME Glancy, A Atkinson, ... International Journal of Drug Policy 131, 104106, 2024 | 2 | 2024 |
| Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study M Glancy, A Yeung, A McAuley, N Palmateer, J Bishop, B Taylor, J Lang, ... Clinical Microbiology and Infection 30 (10), 1312-1318, 2024 | 1 | 2024 |
| SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland A Yeung, M Wilkinson, J Bishop, B Taylor, N Palmateer, L Barnsdale, ... J Epidemiol Community Health 78 (6), 380-387, 2024 | 1 | 2024 |
| Prevalence of opioid dependence in Scotland 2015–2020: A multi‐parameter estimation of prevalence (MPEP) study A Markoulidakis, M Hickman, A McAuley, LR Barnsdale, NJ Welton, ... Addiction, 2024 | 1 | 2024 |
